MRI can be used to identify biochemically distinct subtypes of glioblastoma, new work has shown. In 121 patients at a single institution, quantitative analysis of the shape, texture and edge sharpness of lesions identified three phenotypic clusters in which different molecular pathways were enriched. The clusters were validated in a second cohort of 144 patients from multiple institutions. The imaging approach provides a noninvasive technique for patient stratification and therapeutic optimization.